Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, introduce themselves and give an overview of chronic lymphocytic leukemia (CLL), highlighting symptoms and patient presentation.
A Cancer Drug that Impacted My Life for SLL
After reading a book about how Imbruvica was revolutionized for SLL and CLL, I now have a greater appreciation for the drugs I receive.
Read More
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
We take a look at the first FDA approval in the oncology space for 2024, the Lymphedema Treatment Act and more.
Listen
FDA Approves Easier-to-Swallow Imbruvica Formulation
An oral suspension formula of Imbruvica received the green light from the Food and Drug Administration to be used in all approved indications.
The Treatment Journey of a Patient with CLL
In this episode of the “CURE Talks Cancer” podcast, we spoke with Mark Hoffman, a patient with chronic lymphocytic leukemia, about his diagnosis and treatment journey.
Drug Combos May Help Lower Blood Pressure in Patients Taking Imbruvica
Certain antihypertensive medications may lower blood pressure in patients with blood cancer being treated with Imbruvica or other BTK inhibitors.
Cord Blood-Derived Treatment Shows Promise in Blood Cancer
A CAR NK therapy made from cord blood showed promising responses in patients with relapsed or refractory B-cell malignancies.